II. Definitions
- Atrioventricular Reciprocating Tachycardia (AVRT)
- Form of Paroxysmal Supraventricular Tachycardia (30% of cases) with an accessory pathway (outside the AV Node)
 
 
III. Epidemiology
- Overall, second most common cause of PSVT (30% of cases)
 - Most common in children (represents 60% of SVT cases in first decade of life)
 - Decreasing Prevalence with age (represents 9% of SVT cases over age 70 years)
 
IV. Pathophysiology
V. Findings: EKG
- Heart Rate 160 to 240 (up to 256)
 - Images
 
VI. Types: General
- Orthodromic, narrow complex (87% of cases)
- Signal passes anterograde down the AV Node, through the ventricles and retrograde up the accesory path
 - Represents up to 87% of AVRT cases
 - Narrow Complex Tachycardia at 150 to 250 bpm
 - RP interval is <50% of the tachycardic RR interval
 - Retrograde P Waves appear after the QRS in I, II, III, aVF, V1 (may be obscured by T Wave)
 
 - Antidromic, wide complex
- Signal passes retrograde up the AV Node and anterograde down the accessory path
 - Wide Complex Tachycardia at 150 to 200 bpm
 - RP interval is >50% of the tachycardic RR interval (<100 msec)
 - Short PR Interval
 
 
VII. Types: Variants
- 
                          Wolff-Parkinson-White Syndrome (WPW Syndrome)
- Orthodromic variant
 - Anterograde conduction down the accessory path reaches the ventricle before the AV Nodal signal
 - Results in preexcitation of the ventricle, forming a slurred upstroke of the QRS (delta wave)
 
 - Permanent (or persistent) Junctional Reciprocating Tachycardia
- Slow retrograde conduction via the accessory pathway
 - Results in sustained Supraventricular Tachycardia
 - Risk of Tachycardia induced Cardiomyopathy and Congestive Heart Failure
 
 
VIII. Management
- Catheter Ablation (preferred)
- First-Line Management for recurrent AVRT
 
 - Medical Management (alternative)
- See Paroxysmal Supraventricular Tachycardia
 - See Supraventricular Tachycardia
 - Orthodromic AVRT
- Contraindications to AV Nodal and Rate Control Agents
- Preexcitation such as WPW Syndrome (refer for ablation)
 - Heart Failure with Reduced Ejection Fraction (HFrEF)
 
 - Medications
- Beta Blocker (e.g. Metoprolol)
 - Nondihydropyridine Calcium Channel Blocker (e.g. Diltiazem)
 
 
 - Contraindications to AV Nodal and Rate Control Agents
 - Antidromic AVRT
- Contraindications to Antiarrhythmic Agents
- Ischemic or structural heart disease
 
 - Medications
 
 - Contraindications to Antiarrhythmic Agents
 
 
IX. Course
- May degenerate into Atrial Fibrillation
 
X. References
- Joshi and Dermark (2016) Crit Dec Emerg Med 30(8):3-12
 - Colucci (2010) Am Fam Physician 82(8): 942-52 [PubMed]
 - Delacretaz (2006) N Engl J Med 354(10): 1039-51 [PubMed]
 - Helton (2015) Am Fam Physician 92(9): 793-800 [PubMed]
 - Kumar (2006) Cardiol Clin 24(3): 427-37 [PubMed]
 - Nasir (2023) Am Fam Physician 107(6): 631-41 [PubMed]